Hypoxia inhibits MHC I expression and antigen presentation to escape immune surveillance

Hypoxia inhibits MHC I expression and antigen presentation to escape immune surveillance

Hypoxia is a common feature of solid tumors that has previously been linked to resistance to radiotherapy and chemotherapy, and more recently to immunotherapy. In particular, hypoxic tumors exclude T cells and inhibit their activity, suggesting that tumor cells acquire a mechanism to evade T cell re...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Estephan, H, Tailor, A, Parker, R, Kreamer, M, Papandreou, I, Campo, L, Easton, A, Moon, EJ, Denko, N, Ternette, N, Hammond, E, Giaccia, A
Natura:	Journal article
Lingua:	English
Pubblicazione:	EMBO Press 2025

Documenti analoghi

Mass spectrometry–based identification of MHC-bound peptides for immunopeptidomics
di: Purcell, A, et al.
Pubblicazione: (2019)

MHC antigens and cancer: implications for T-cell surveillance.
di: Browning, M, et al.
Pubblicazione: (1992)

Hypoxia-mediated regulation of DDX5 through decreased chromatin accessibility and post-translational targeting restricts R-loop accumulation
di: Leszczynka, K, et al.
Pubblicazione: (2023)

Dual roles of NRF2 in tumor prevention and progression: possible implications in cancer treatment
di: Moon, EJ, et al.
Pubblicazione: (2014)

Identification of antigens presented by MHC for vaccines against tuberculosis
di: Bettencourt, P, et al.
Pubblicazione: (2020)

Identification of antigens presented by MHC for vaccines against tuberculosis
di: Bettencourt, P, et al.
Pubblicazione: (2020)

Angiogenesis: escape from hypoxia.
di: Coleman, M, et al.
Pubblicazione: (2009)

NNAlign_MA; MHC peptidome deconvolution for accurate MHC binding motif characterization and improved T-cell epitope predictions
di: Alvarez, B, et al.
Pubblicazione: (2019)

Hypoxia‐mediated regulation of DDX5 through decreased chromatin accessibility and post‐translational targeting restricts R‐loop accumulation
di: Katarzyna B. Leszczynska, et al.
Pubblicazione: (2023-07-01)

Direct Identification of Vaccine-Induced HIV-1-Specific MHC Class I Associated Epitopes by Mass Spectrometry
di: Ternette, N, et al.
Pubblicazione: (2013)

Hypoxia-Driven Immune Escape in the Tumor Microenvironment
di: Alyssa Vito, et al.
Pubblicazione: (2020-04-01)

Identification of novel mycobacterial antigens presented by MHC-I and -II by immunopeptidomics for vaccines against tuberculosis
di: Bettencourt, P, et al.
Pubblicazione: (2019)

NetMHCphosPan - Pan-specific prediction of MHC class I antigen presentation of phosphorylated ligands
di: Carina Thusgaard Refsgaard, et al.
Pubblicazione: (2021-10-01)

Dynamic regulation of mitochondrial pyruvate metabolism is necessary for orthotopic pancreatic tumor growth
di: Nancy P. Echeverri Ruiz, et al.
Pubblicazione: (2021-11-01)

Targeting hypoxia: Revival of old remedies
di: Vilaplana-Lopera, N, et al.
Pubblicazione: (2021)

Editorial: Hypoxia and angiogenesis in cancer
di: Mohammad Malekan, et al.
Pubblicazione: (2024-08-01)

Inhibition of Autophagy by Berbamine Hydrochloride Mitigates Tumor Immune Escape by Elevating MHC-I in Melanoma Cells
di: Jinhuan Xian, et al.
Pubblicazione: (2024-09-01)

The SysteMHC Atlas project.
di: Shao, W, et al.
Pubblicazione: (2017)

Downregulation of type I IFN response in hypoxia as a possible mechanism of immune escape
di: Miar, A, et al.
Pubblicazione: (2019)

Mechanisms Of Hypoxia-Induced Immune Escape In Cancer And Their Regulation By Nitric Oxide
di: Charles Graham, et al.
Pubblicazione: (2015-08-01)

Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape
di: Qinghua Wu, et al.
Pubblicazione: (2022-06-01)

The Avian MHC-Antigen System
di: Diana Wesselinova
Pubblicazione: (2002-10-01)

Of mice and the MHC.
di: Grafen, A
Pubblicazione: (1992)

MARCH1-mediated ubiquitination of MHC II impacts the MHC I antigen presentation pathway.
di: Kayla R Wilson, et al.
Pubblicazione: (2018-01-01)

MECHANISM OF MHC-MEDIATED ANTIGEN RECOGNITION BY T-CELLS
di: Bowness, P, et al.
Pubblicazione: (1993)

ROS and cGMP signaling modulate persistent escape from hypoxia in Caenorhabditis elegans.
di: Lina Zhao, et al.
Pubblicazione: (2022-06-01)

Monoclonal antibodies to rat leukocyte surface antigens, MHC antigens, and immunoglobulins.
di: Puklavec, M, et al.
Pubblicazione: (2001)

Mutational Escape in HIV-1 CTL Epitopes Leads to Increased Binding to Inhibitory Myelomonocytic MHC Class I Receptors
di: Yang, Yue, et al.
Pubblicazione: (2011)

Mutational escape in HIV-1 CTL epitopes leads to increased binding to inhibitory myelomonocytic MHC class I receptors.
di: Yue Yang, et al.
Pubblicazione: (2010-12-01)

Cysteine allows ovarian cancer cells to adapt to hypoxia and to escape from carboplatin cytotoxicity
di: Sofia C. Nunes, et al.
Pubblicazione: (2018-06-01)

Cognate MHC-TCR interaction leads to apoptosis of antigen-presenting cells.
di: Setterblad, N, et al.
Pubblicazione: (2004)

Bringing H2AX into the angiogenesis family.
di: Rankin, E, et al.
Pubblicazione: (2009)

Oxygen sensing and the DNA-damage response.
di: Hammond, E, et al.
Pubblicazione: (2007)

Oxygen consumption can regulate the growth of tumors, a new perspective on the Warburg effect.
di: Yijun Chen, et al.
Pubblicazione: (2009-09-01)

Folding of an MHC class II-restricted tumor antigen controls its antigenicity via MHC-guided processing.
di: Mimura, Y, et al.
Pubblicazione: (2007)

Functions of nonclassical MHC and non-MHC-encoded class I molecules.
di: Braud, V, et al.
Pubblicazione: (1999)

CA IX Stabilizes Intracellular pH to Maintain Metabolic Reprogramming and Proliferation in Hypoxia
di: Martin Benej, et al.
Pubblicazione: (2020-09-01)

Tumor‐Associated Macrophage‐Derived Exosomal LINC01232 Induces the Immune Escape in Glioma by Decreasing Surface MHC‐I Expression
di: Junjun Li, et al.
Pubblicazione: (2023-06-01)

Maintenance of MHC polymorphism.
di: Hughes, A, et al.
Pubblicazione: (1992)

Role of Trypanosoma cruzi trans-sialidase on the escape of host immune surveillance
di: Ana Flávia Fernandes Ribas Nardy, et al.
Pubblicazione: (2016-03-01)